Sylvania Platinum (SLP) Competitors

Dr. Martens (LON:DOCS) and Sylvania Platinum (LON:SLP) are both small-cap computer software companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

Do insiders and institutionals hold more shares of DOCS or SLP?

22.0% of Dr. Martens shares are owned by institutional investors. Comparatively, 11.8% of Sylvania Platinum shares are owned by institutional investors. 2.8% of Dr. Martens shares are owned by insiders. Comparatively, 4.8% of Sylvania Platinum shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is DOCS or SLP more profitable?

Sylvania Platinum has a net margin of 8.55% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Sylvania Platinum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	7.89%	18.91%	8.12%
Sylvania Platinum	8.55%	2.82%	1.69%

Which has preferable earnings & valuation, DOCS or SLP?

Dr. Martens has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£787.60M	1.12	£68.97M	£0.01	18,310.00
Sylvania Platinum	£104.23M	2.38	£8.54M	£0.08	1,231.57

Is DOCS or SLP a better dividend stock?

Dr. Martens pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.0%. Sylvania Platinum pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.0%. Dr. Martens pays out 368.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sylvania Platinum pays out 29.0% of its earnings in the form of a dividend. Sylvania Platinum is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has more volatility & risk, DOCS or SLP?

Dr. Martens has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, Sylvania Platinum has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.

Does the media favor DOCS or SLP?

In the previous week, Sylvania Platinum had 2 more articles in the media than Dr. Martens. MarketBeat recorded 3 mentions for Sylvania Platinum and 1 mentions for Dr. Martens. Sylvania Platinum's average media sentiment score of 0.84 beat Dr. Martens' score of 0.00 indicating that Sylvania Platinum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dr. Martens	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sylvania Platinum	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend DOCS or SLP?

Dr. Martens presently has a consensus price target of GBX 6,000, indicating a potential upside of 6,453.80%. Sylvania Platinum has a consensus price target of GBX 106, indicating a potential upside of 11.34%. Given Dr. Martens' higher possible upside, research analysts plainly believe Dr. Martens is more favorable than Sylvania Platinum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Sylvania Platinum	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Sylvania Platinum beats Dr. Martens on 10 of the 17 factors compared between the two stocks.